Clinical Trial Detail

NCT ID NCT04117958
Title Study of AMG 199 in Subjects With MUC17-Positive Gastric and Gastroesophageal Junction Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

AMG 199

Age Groups: senior adult

No variant requirements are available.